ATE397667T1 - Fruktosyltransferase (inulosucrase und levansucrase) von lactobacillus reuteri - Google Patents

Fruktosyltransferase (inulosucrase und levansucrase) von lactobacillus reuteri

Info

Publication number: ATE397667T1
Authority: AT; Austria
Prior art keywords: inulosucrase; levansucrase; lactobacillus reuteri; fructosyl transferase; levan
Prior art date: 2000-05-25

Application number

AT01934630T

Other languages

English (en)

Inventor

Geel-Schutten Gerritdina Van

Hakim Rahaoui

Lubbert Dijkhuizen

Hijum Sacha Van

Original Assignee

Tno

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-25

Filing date

2001-05-23

Publication date

2008-06-15

2001-05-23 Application filed by Tno filed Critical Tno

2008-06-15 Application granted granted Critical

2008-06-15 Publication of ATE397667T1 publication Critical patent/ATE397667T1/de

Links

108010042889 Inulosucrase Proteins 0.000 title abstract 4
241000186604 Lactobacillus reuteri Species 0.000 title 1
108010036940 Levansucrase Proteins 0.000 title 1
229940001882 lactobacillus reuteri Drugs 0.000 title 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 2
229920001202 Inulin Polymers 0.000 abstract 2
241000186660 Lactobacillus Species 0.000 abstract 2
235000021472 generally recognized as safe Nutrition 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000790 Enzymes Proteins 0.000 abstract 1
102000004190 Enzymes Human genes 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
239000006041 probiotic Substances 0.000 abstract 1
230000000529 probiotic effect Effects 0.000 abstract 1
235000018291 probiotics Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1055—Levansucrase (2.4.1.10)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Mycology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT01934630T 2000-05-25 2001-05-23 Fruktosyltransferase (inulosucrase und levansucrase) von lactobacillus reuteri ATE397667T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00201872		2000-05-25
EP01200049		2001-01-09

Publications (1)

Publication Number	Publication Date
ATE397667T1 true ATE397667T1 (de)	2008-06-15

Family

ID=26072301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01934630T ATE397667T1 (de)	2000-05-25	2001-05-23	Fruktosyltransferase (inulosucrase und levansucrase) von lactobacillus reuteri

Country Status (8)

Country	Link
EP (1)	EP1283888B1 (de)
AT (1)	ATE397667T1 (de)
AU (2)	AU2001260791B2 (de)
CA (1)	CA2409965A1 (de)
DE (1)	DE60134313D1 (de)
DK (1)	DK1283888T3 (de)
ES (1)	ES2307616T3 (de)
WO (1)	WO2001090319A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1357180A1 (de) *	2002-04-09	2003-10-29	Société des Produits Nestlé S.A.	Levansucrase von lactobacillus johnsonii
DE10355302A1 (de) *	2003-11-27	2005-06-23	Technische Universität München	Verfahren zur fermentativen Anreicherung von Lebensmitteln mit Fructose-Oligosacchariden
JP2008501316A (ja) *	2004-04-20	2008-01-24	ザユニヴァーシティーオヴシカゴ	ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用
WO2006100253A2 (de) *	2005-03-22	2006-09-28	Technische Universität Braunschweig	Verfahren zur oligosaccharidsynthese oder zur glykosylierung unter verwendung von glycosyltransferasen und saccharose-analoga
US20140227690A1 (en) *	2013-02-08	2014-08-14	St. John Heallth	Methods and compositions for assessment of fetal lung maturity
JP6730281B2 (ja) *	2014-12-05	2020-07-29	ダニスコ・ユーエス・インク	バチルス・アガラドヘレンス（ｂａｃｉｌｌｕｓａｇａｒａｄｈａｅｒｅｎｓ）イヌロスクラーゼ（ｉｎｕｏ）の使用を含む組成物および方法
CN105907815A (zh) *	2016-05-25	2016-08-31	四川大学	一种高均一度大分子量Levan型果聚糖的制备方法
KR102237465B1 (ko) *	2019-12-18	2021-04-07	한국생명공학연구원	이눌로수크라제 활성이 도입된 효모 및 이를 이용한 프럭토올리고사카라이드 생산방법
GB202017421D0 (en) *	2020-11-03	2020-12-16	Inulox Ltd	Enzyme method
US11488371B2 (en)	2020-12-17	2022-11-01	Concat Systems, Inc.	Machine learning artificial intelligence system for producing 360 virtual representation of an object

2001
- 2001-05-23 WO PCT/NL2001/000392 patent/WO2001090319A2/en not_active Ceased
- 2001-05-23 EP EP01934630A patent/EP1283888B1/de not_active Expired - Lifetime
- 2001-05-23 AU AU2001260791A patent/AU2001260791B2/en not_active Ceased
- 2001-05-23 DK DK01934630T patent/DK1283888T3/da active
- 2001-05-23 DE DE60134313T patent/DE60134313D1/de not_active Expired - Lifetime
- 2001-05-23 AU AU6079101A patent/AU6079101A/xx active Pending
- 2001-05-23 CA CA002409965A patent/CA2409965A1/en not_active Abandoned
- 2001-05-23 ES ES01934630T patent/ES2307616T3/es not_active Expired - Lifetime
- 2001-05-23 AT AT01934630T patent/ATE397667T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2001090319A2 (en)	2001-11-29
EP1283888A2 (de)	2003-02-19
AU2001260791B2 (en)	2006-11-09
WO2001090319A3 (en)	2002-08-15
AU6079101A (en)	2001-12-03
CA2409965A1 (en)	2001-11-29
EP1283888B1 (de)	2008-06-04
ES2307616T3 (es)	2008-12-01
DK1283888T3 (da)	2008-10-13
DE60134313D1 (de)	2008-07-17

Similar Documents

Publication	Publication Date	Title
ATE397667T1 (de)	2008-06-15	Fruktosyltransferase (inulosucrase und levansucrase) von lactobacillus reuteri
ATE395415T1 (de)	2008-05-15	Campylobacter glycolsyltransferasen zur verwendung bei der biosynthese von gangliosiden und ganglioside imitatoren
DE602005010231D1 (de)	2008-11-20	Nachweis und typisierung von lactobacillus bakterienstämmen
AR042313A1 (es)	2005-06-15	Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal
NZ510819A (en)	2004-03-26	Polyketide synthase enzymes and recombinant DNA constructs therefor
DK1359816T3 (da)	2005-08-15	Kombination af probiotika
WO2002044350A3 (de)	2003-03-13	Cyclodextrin-glucanotransferase (cg tase) aus bicillus agaradherens (dsm 9948) sowie wasch- und reinigungsmittel mit dieser neuen cyclodextrin-glucanotransferase
EA200201248A1 (ru)	2003-06-26	Применение lactobacillus casei в иммуностимуляторных пептидах
PL2173196T3 (pl)	2011-06-30	Zastosowanie probiotyków i włókien w biegunce
NZ593708A (en)	2013-05-31	Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
WO2001090317A3 (en)	2002-04-25	Beta-galactosidase isolated from a bifidobacterium
EP2805625A3 (de)	2015-03-25	Ernährungszusammensetzung mit Probiotika
EP1914302A3 (de)	2008-07-23	Campylobacter-Glycosyltranferasen für die Biosynthese von Gangliosiden und Gangliosid-Nachahmern
MX356598B (es)	2018-06-04	Bifidobacterium longum.
EA200101262A1 (ru)	2002-04-25	Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
DK1789531T3 (da)	2011-01-10	Lactobacillus rhamnosus med kropsfedt-mindskende aktivitet og fødevarer indeholdende dem
ATE319848T1 (de)	2006-03-15	Herstellung von polyketiden
WO2023137381A3 (en)	2023-09-28	Bifidobacterium infantis formulations
IL177179A (en)	2012-04-30	Fusion protein comprising truncated n-acetylgalactosaminyltransferase 2 (galnact2) and maltose binding domain
GT200000138CA (es)	2002-02-02	Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138)
DK1332223T3 (da)	2007-11-12	Fremgangsmåde til screening for probiotiske stammer af slægten Bifidobacterium
BG104759A (en)	2001-04-30	Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
UA27734U (en)	2007-11-12	Method for correcting impaired mineral metabolism in children with allergic diathesis
KR960034401A (ko)	1996-10-22	프로바이오틱에 적합한 비피더스균 및 그의 분말 비피더스균 제제
Saarela et al.	2004	Gut feeling.

Legal Events

Date	Code	Title	Description
2008-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties